Methyl hydrazinecarbimidothioate hydroiodide
CAS: 35600-34-1
Ref. 3D-FM133227
| 1g | A consultar | ||
| 2g | A consultar | ||
| 5g | A consultar | ||
| 10g | A consultar | ||
| 25g | A consultar |
Información del producto
- Hydrazinecarboximidothioic acid methyl ester hydroiodide
- Carbamohydrazonothioic Acid, Methyl Ester
Methyl hydrazinecarbimidothioate hydroiodide (MHCDI) is an anti-cancer drug that belongs to the group of alkylating agents. It is a prodrug that must be activated by intramolecular hydrogen chloride to form methyl hydrazine, which reacts with the DNA nucleotide bases. MHCDI is used in clinical studies for the treatment of pancreatic cancer, colorectal cancer, and other cancers. MHCDI is administered intravenously, orally, or intraperitoneally. MHCDI binds to nitrogen atoms in the vasoactive intestinal peptide and reacts with hydrochloric acid to form a pyrazole ring. The reaction products are then excreted from the body.
Propiedades químicas
Consulta técnica sobre: 3D-FM133227 Methyl hydrazinecarbimidothioate hydroiodide
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
